Corroborating evidence-based medicine

被引:5
作者
Mebius, Alexander [1 ]
机构
[1] Royal Inst Technol KTH, Dept Philosophy & Hist Technol, S-10044 Stockholm, Sweden
关键词
corroboration; evidence-based medicine; mechanisms; meta-analysis; quality of evidence; randomized control trials; RANDOMIZED CONTROLLED-TRIALS; INTERVENTIONS; MECHANISMS; CAUSALITY; REVIEWS;
D O I
10.1111/jep.12129
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Proponents of evidence-based medicine (EBM) have argued convincingly for applying this scientific method to medicine. However, the current methodological framework of the EBM movement has recently been called into question, especially in epidemiology and the philosophy of science. The debate has focused on whether the methodology of randomized controlled trials provides the best evidence available. This paper attempts to shift the focus of the debate by arguing that clinical reasoning involves a patchwork of evidential approaches and that the emphasis on evidence hierarchies of methodology fails to lend credence to the common practice of corroboration in medicine. I argue that the strength of evidence lies in the evidence itself, and not the methodology used to obtain that evidence. Ultimately, when it comes to evaluating the effectiveness of medical interventions, it is the evidence obtained from the methodology rather than the methodology that should establish the strength of the evidence.
引用
收藏
页码:915 / 920
页数:6
相关论文
共 44 条
[1]   Mechanisms: what are they evidence for in evidence-based medicine? [J].
Andersen, Holly .
JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 2012, 18 (05) :992-999
[2]  
[Anonymous], LEV EV
[3]   A comparison of observational studies and randomized, controlled trials. [J].
Benson, K ;
Hartz, AJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (25) :1878-1886
[4]  
Bero L., 2012, COCHRANE DB SYST REV
[5]   Physiological mechanisms and epidemiological research [J].
Bluhm, Robyn .
JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 2013, 19 (03) :422-426
[6]  
Bluhm R, 2007, PHILOS MED, V90, P149
[7]  
Britton A., 1998, HEALTH TECHNOL ASSES, V2, P1, DOI DOI 10.1136/BMJ.317.7167.1258A
[8]  
Cartwright N., 2007, BIOSOCIETIES, V2, P11, DOI [10.1017/S1745855207005029, DOI 10.1017/S1745855207005029]
[9]  
Cartwright N., 2008, DAPPLED WORLD STUDY
[10]  
Committee for Medicinal Products for Human Use (CHMP) et al, 2009, GUID CLIN EV DIAGN A